France allows shorter gap between first and second Covid blow – –

0
17
France allows shorter gap between first and second Covid blow – –


France is closing the gap between the first and second dose of Pfizer and Moderna Covid-19 vaccines to ensure people are fully vaccinated quickly and do not postpone a second vaccine due to the summer vacation.
Health Minister Olivier Véran said yesterday on Twitter (June 15): “Are you waiting to be vaccinated in June because you will be on vacation in July?” Do not hesitate. We are modifying the appointment system to allow you to schedule your second appointment between 21 and 49 days after the first.

Previously, the allowed deviation was between 35 and 49 days. The new rules apply to mRNA vaccines, Pfizer / BioNTech and Moderna, which are the types most used in France.

The change is to give more flexibility to people seeking a first jab who may differ otherwise as they are absent afterwards and therefore may not be able to get a second jab at the tighter previous moment.

Mr Véran said that there may be exceptions that allow people to get their second dose of the vaccine at their vacation spot rather than in their hometown, but that should not become “the rule” for the city. most vacationers.

Delta protection

He added that he wanted to speed up access to second injections in order to “protect [the population] as much as possible “.

This is especially the case due to the increasing number of cases of the Delta (or “Indian”) variant, which is 60% more contagious than the Alpha (“UK”) variant.

The figures published in a medical journal The Lancette show that after complete vaccination (all doses administered), after two weeks, the Pfizer / BioNTech vaccine offers 79% protection against serious diseases of the Delta variant, against 92% for the Alpha variant. After full vaccination (all doses), the vaccine protection of AstraZeneca fell to 60% against the Delta variant, compared to 73% against the Alpha.

The numbers show that four weeks after a single dose, the Pfizer jab offers 36% protection against severe disease of the Delta variant, and AstraZeneca 30%. This contrasts with the Alpha variant, against which both vaccines had shown 50% protection against serious illness after a single dose.

The Pfizer / BioNTech vaccine has been shown to have 94% vaccine efficacy against hospitalization due to the Delta variant after one dose and 96% after two doses. The figures for the AstraZeneca vaccine were 71% and 92%, respectively.

Read more: Between 2 and 4% of positive Covid tests in France show a Delta variant

Vaccine targets

The Minister of Health did not specify specific targets for the vaccination campaign in terms of the number of people vaccinated out of the entire adult population, but he said he wanted to go “as far as possible”, for example. , at least 90% vaccinated for people over 75 years old. The current figure is just over 80% in this age group.

He said that France would receive “many vaccines in June”, and that it was “important that a large part of the public make an appointment”.

France is expected to receive 23 million doses of vaccines – mainly Pfizer and Moderna – in June, according to the mentioned Economy Ministry.

Mr Véran said: “In January, only 50% of the French public intended to be vaccinated, due to fears about vaccines…[now], 80% want to be vaccinated, which makes France one of the first countries for mRNA vaccines, in particular Pfizer, without fear.

Related stories

France improves Covid-19 tests to better track the spread of the Delta variant
“90% vaccination necessary for collective immunity in France”
How is France following the spread of the Indian variant of Covid-19?



LEAVE A REPLY

Please enter your comment!
Please enter your name here